about
Predictive diagnostic value for the clinical features accompanying intellectual disability in children with pathogenic copy number variations: a multivariate analysis.The clinical impact of chromosomal microarray on paediatric care in Hong Kong.Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.The genetics of microdeletion and microduplication syndromes: an update.Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarrayParents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disordersClinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician PracticesGenomeCAT: a versatile tool for the analysis and integrative visualization of DNA copy number variants.Analytical and Clinical Validity Study of FirstStepDx PLUS: A Chromosomal Microarray Optimized for Patients with Neurodevelopmental Conditions.Low Rates of Genetic Testing in Children With Developmental Delays, Intellectual Disability, and Autism Spectrum Disorders.CNV analysis in Chinese children of mental retardation highlights a sex differentiation in parental contribution to de novo and inherited mutational burdensWhat Do Parents Think about Chromosomal Microarray Testing? A Qualitative Report from Parents of Children with Autism Spectrum Disorders.Utilization of genetic testing among children with developmental disabilities in the United States.Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental DisordersPathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays.Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies.Genetic Testing in Dermatology: A Survey Analyzing Obstacles to Appropriate Care.Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder.Genomic Variation: Lessons Learned from Whole-Genome CNV Analysis.Clinical performance of the CytoScan Dx Assay in diagnosing developmental delay/intellectual disability.Current use of chromosomal microarray by Australian paediatricians and implications for the implementation of next generation sequencing.The impact of chromosomal microarray on clinical management: a retrospective analysis.The Diagnostic Yield of Array Comparative Genomic Hybridization Is High Regardless of Severity of Intellectual Disability/Developmental Delay in Children.Prematurity, ventricular septal defect and dysmorphisms are independent predictors of pathogenic copy number variants: a retrospective study on array-CGH results and phenotypical features of 293 children with neurodevelopmental disorders and/or multChromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual DisabilityExome sequencing for paediatric-onset diseases: impact of the extensive involvement of medical geneticists in the diagnostic odyssey
P2860
Q33582837-C67CCC0F-2923-4296-84E3-C2E78FB9EFADQ34343633-A9AE2E6A-6378-4309-9357-1EB140266E10Q34547121-CA2DA421-9434-401A-A77C-3AAD055A0B29Q35765523-68F5E1D2-5E13-482D-A23C-1B9A3F2A179BQ35959752-0F602902-1A01-4CFC-B3CE-81E20A3F34DBQ36068717-B949E995-E63D-4620-A3EB-F9176E3EF14EQ36236352-59712049-1C39-4CCF-B38B-CD760ECED80EQ36243060-A3CB4886-C1AB-4A00-B989-13AAEBFCFB21Q36327651-AE48A9B6-CFF4-42E2-A5DC-04BEDBB25589Q36668794-E5EC5B74-5606-41D0-9F35-CA0411AF4CF7Q36965064-A2B9FFCF-6FA3-4671-A20D-957CDC6CC682Q37060658-94547FD8-CB20-4E43-A444-8E5B65DF1F74Q37098689-DF7E4BFC-D5FC-45E2-A46F-8CB072FC9EDEQ37453434-4D45924B-64D1-494F-8B48-269C3EFAE7FAQ37470598-28BEEE17-4249-4FAC-9BEF-0526BD591A7DQ39127499-B21454C4-1BEF-4A33-8F7D-90502E067AD5Q39366341-FDC35C38-413F-4156-A687-FC0285660253Q42362268-304F039E-D54D-483F-9D2F-BD0694621764Q42783360-CDB79B45-BE50-4B55-AAF9-C688D76C0E4AQ46344675-2E546179-1D98-445B-A265-80D3B722FA85Q48658445-E80972B4-F334-4C1A-9541-EA0C84009674Q50308309-A770009A-DE02-4FD0-A7DF-B0A444CDBF93Q50552403-08464C83-39FC-42AB-83F6-3765F9C3BE4FQ52664033-07C0FFDB-B140-4132-8608-45EAC85FEDF2Q57213134-BEBA0AC0-CE21-4714-9B65-A59D8451B959Q58799601-B0140D7A-76B3-47A6-A35B-3A8464907B62
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Chromosomal microarray impacts clinical management.
@en
Chromosomal microarray impacts clinical management.
@nl
type
label
Chromosomal microarray impacts clinical management.
@en
Chromosomal microarray impacts clinical management.
@nl
prefLabel
Chromosomal microarray impacts clinical management.
@en
Chromosomal microarray impacts clinical management.
@nl
P2093
P2860
P356
P1433
P1476
Chromosomal microarray impacts clinical management.
@en
P2093
B Smith-Packard
D Riethmaier
D T Miller
E C Thorland
W A Faucett
P2860
P304
P356
10.1111/CGE.12107
P577
2013-02-21T00:00:00Z